Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate

We are Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate CAS:917392-54-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate
CAS.NO:917392-54-2
Synonyms:Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate
Benzoic acid, 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-, methyl ester
 
Physical and Chemical Properties:
Density 1.3±0.1 g/cm3
Boiling Point 538.6±60.0 °C at 760 mmHg
Molecular Formula C18H16N4O2
Molecular Weight 320.345
Flash Point 279.5±32.9 °C
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.634
 
Specification:
Appearance:Off-white to light yellow crystalline powder
Assay(HPLC):≥99.0%
Moisture:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Nilotinib hcl monohydrate(CAS:923288-90-8/923288-95-3).

Methyl 4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzoate


Related News: “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”N- (4-aminofenil) -N-metil-2- (4-metilpiperazin-1-il) acetamida CAS:262368-30-9 Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies.4'-cloro-2 ', 5'-dimetoxiacetoacetanilida CAS:4433-79-8 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.5-azacytosine CAS:931-86-2 Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.

Related Products
Product Name
Glycylglycylglycine View Details
Ethyl (1E)-N-cyanoethanimidate View Details
2,3-Difluorobenzotrifluoride View Details
N-Fmoc-N’-trityl-L-histidine manufacturer N-(tert-butoxycarbonyl)piperidin-2-one manufacturer 4,4-dimethoxy-N,N-dimethylbutan-1-amine manufacturer tert-Butylisocyanate manufacturer 5-amino-1-(N-methylcarbamoyl)imidazole-4-carboxamide manufacturer